MD Medical Group Successfully Completes Long-Term Management Incentive Programme
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has successfully completed its long-term share incentive programme (the “Programme”) aimed at senior management and key personnel on achieving all KPIs set out in the Programme.
The Programme had 40 participants. 13% of the remuneration will be paid in cash, and the rest will be paid as 187,659 GDRs. It is expected that the payments will be made by the end of Q2 2018.
|
Name |
Position |
GDRs to be distributed |
|
Andrey Khoperskiy |
Deputy CEO for Economics and Finance |
6,960 |
|
Boris Konoplev |
Medical Director of Mother&Child, Head of Hospital Group |
6,943 |
|
Yulia Kutakova |
Medical Director for Organizational and Scientific-educational Work |
4,959 |
|
Alsou Nazyrova |
Director of Mother&Child Urals, Board Member |
6,960 |
|
Alexander Rayt |
Deputy CEO for Operations |
6,960 |
|
Marat Tugushev |
Director of Mother&Child Volga |
4,959 |
|
Natalia Yakunina |
Deputy CEO for Patient Care |
6,960 |
Other participants of the Programme (doctors, etc.) who are not PDMR and/or PCA will in total receive 142,958 of the Company’s GDRs.
For further information please contact:
|
Investors |
Media |
|
Dmitry Yakushkin
MD Medical Group Investments Plc
Tel: +7 495 331 4120 d.yakushkin@mcclinics.ru |
EM
Tom Blackwell: +7 919 102 9064 Sergii Pershyn: +1 929 855 8188
|
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 36 modern healthcare facilities, including 5 hospitals and 31 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, and Nizhny Novgorod.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.